Financial news, mergers and acquisitions, partnerships, and alliances.
Eurofins will distribute Synthego's sgRNA products to its customers in 44 countries.
The drop in CGI's third quarter revenues reflect declines across the company's biopharma, clinical, and discovery services units.
The company reported revenues of $21.7 million compared to $11.1 million in the year-ago quarter, overshooting analysts' expectations of $17.5 million.
The firm saw growth of 8 percent in its life science business, 9 percent in its crosslabs group, and 9 percent in its diagnostics and genomics division in Q4.
The company submitted the test to Japanese regulators for approval as a companion diagnostic for Daiichi Sankyo's acute myeloid leukemia drug quizartinib.
In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.
An opinion piece at Bloomberg discusses China's stance on genomic research.
Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.
Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.